ALD-451

N/A

Report date: 2023/02/17 21:03:13

Base Information

Drug NameALD-451
Drug Alias NameALD-451
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDuke University Medical CenterCytomedix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytomedixDuke University Medical Center
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A